Interactions Between Immune and Bone Cells: New Insights with Many Remaining Questions

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2000 Sep 21

PMID 10995785

Citations 48

Authors

J Lorenzo

Affiliations

Soon will be listed here.

Citing Articles

Association between modified dietary inflammation index score and lumbar vertebrae bone mineral density in patients with hypertension: data from NHANES-a population-based study.

Chen G, Qu B, Liu P, Zhang Z Nutr Metab (Lond). 2024; 21(1):102.

PMID: 39633453 PMC: 11616204. DOI: 10.1186/s12986-024-00877-x.

Use of Local Melatonin with Xenogeneic Bone Graft to Treat Critical-Size Bone Defects in Rats with Osteoporosis: A Randomized Study.

Costa K, Abreu L, Tolomei C, Eleuterio R, Basting R, Balbinot G J Funct Biomater. 2024; 15(5).

PMID: 38786635 PMC: 11122056. DOI: 10.3390/jfb15050124.

An in silico approach to elucidate the pathways leading to primary osteoporosis: age-related vs. postmenopausal.

Ruiz-Lozano R, Calvo-Gallego J, Pivonka P, McDonald M, Martinez-Reina J Biomech Model Mechanobiol. 2024; 23(4):1393-1409.

PMID: 38700787 PMC: 11584493. DOI: 10.1007/s10237-024-01846-2.

Integrating osteoimmunology and nanoparticle-based drug delivery systems for enhanced fracture healing.

Xiao B, Adjei-Sowah E, Benoit D Nanomedicine. 2023; 56:102727.

PMID: 38056586 PMC: 10872334. DOI: 10.1016/j.nano.2023.102727.

CpG ODN/Mangiferin Dual Delivery through Calcium Alginate Hydrogels Inhibits Immune-Mediated Osteoclastogenesis and Promotes Alveolar Bone Regeneration in Mice.

Gu Y, Hu Y, Huang S, Ruiz S, Kawai T, Bai Y Biology (Basel). 2023; 12(7).

PMID: 37508406 PMC: 10376397. DOI: 10.3390/biology12070976.

References

Teng Y, Nguyen H, Gao X, Kong Y, Gorczynski R, Singh B . Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 2000; 106(6):R59-67. PMC: 3102542. DOI: 10.1172/jci10763. View

Ross F . RANKing the importance of measles virus in Paget's disease. J Clin Invest. 2000; 105(5):555-8. PMC: 292462. DOI: 10.1172/JCI9557. View

Horton J, Raisz L, Simmons H, Oppenheim J, Mergenhagen S . Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science. 1972; 177(4051):793-5. DOI: 10.1126/science.177.4051.793. View

Dewhirst F, Stashenko P, Mole J, Tsurumachi T . Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta. J Immunol. 1985; 135(4):2562-8. View

Bertolini D, Nedwin G, Bringman T, Smith D, Mundy G . Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986; 319(6053):516-8. DOI: 10.1038/319516a0. View

Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M . Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A. 1987; 84(13):4616-20. PMC: 305141. DOI: 10.1073/pnas.84.13.4616. View

Ishimi Y, Miyaura C, Jin C, Akatsu T, Abe E, Nakamura Y . IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990; 145(10):3297-303. View

Roodman G, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A . Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest. 1992; 89(1):46-52. PMC: 442817. DOI: 10.1172/JCI115584. View

Jilka R, Hangoc G, Girasole G, Passeri G, Williams D, Abrams J . Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992; 257(5066):88-91. DOI: 10.1126/science.1621100. View

10.

Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H . Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994; 13(5):1189-96. PMC: 394928. DOI: 10.1002/j.1460-2075.1994.tb06368.x. View

11.

Devlin R, Bone 3rd H, Roodman G . Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab. 1996; 81(5):1893-7. DOI: 10.1210/jcem.81.5.8626854. View

12.

Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M . Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest. 1996; 98(1):30-5. PMC: 507397. DOI: 10.1172/JCI118773. View

13.

Prockop D . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276(5309):71-4. DOI: 10.1126/science.276.5309.71. View

14.

Ammann P, Rizzoli R, Bonjour J, Bourrin S, Meyer J, Vassalli P . Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest. 1997; 99(7):1699-703. PMC: 507990. DOI: 10.1172/JCI119333. View

15.

Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, Luthy R . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2):309-19. DOI: 10.1016/s0092-8674(00)80209-3. View

16.

Wong B, Rho J, Arron J, Robinson E, Orlinick J, Chao M . TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem. 1997; 272(40):25190-4. DOI: 10.1074/jbc.272.40.25190. View

17.

Anderson D, Maraskovsky E, Billingsley W, Dougall W, Tometsko M, Roux E . A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997; 390(6656):175-9. DOI: 10.1038/36593. View

18.

Guise T, Mundy G . Cancer and bone. Endocr Rev. 1998; 19(1):18-54. DOI: 10.1210/edrv.19.1.0323. View

19.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S . Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998; 95(7):3597-602. PMC: 19881. DOI: 10.1073/pnas.95.7.3597. View

20.

Lacey D, Timms E, Tan H, Kelley M, Dunstan C, Burgess T . Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998; 93(2):165-76. DOI: 10.1016/s0092-8674(00)81569-x. View